Biochemistry Flashcards
DNA methylation at CpG islands results in
Repression of transcription
Amino acids necessary for purine synthesis
- Glycine
- Aspartate
- Glutamine
“GAG”
Drugs that disrupt pyrimidine synthesis
- LEFLUNOMIDE (inhibits dihydroorate reductase)
- METHOTREXATE, TRIMETHOPRIM, PYRIMETHANAMINE (inhibit dihydrofolate reducts which results in decreased dexoythymidine monophosphase [dTMP] in humans, bacteria, and protozoa, respectively)
- 5-FLUOROURACIL (forms 5-F-dUMP, which inhibits thymidylate synthase and decreases dTMP)
Drugs that disrupt purine synthesis
- 6-MERCAPTOPURINE, AZATHIOPRINE (inhibit de novo purine synthesis)
- MYCOPHENOLATE, RIBAVIRIN (inhibit inosine monophosphate dehydrogenase)
Drugs that disrupt purine and pyrimidine synthesis
- HYDROXYUREA (inhibits ribonucleotide reductase)
Reaction catalyzed by HGPRT
Hypoxanthine + PRPP → IMP
Guanine + PRPP → GMP
DNA polymerase III
- Prokaryotic only
- Elongates leading strand by adding deoxynucleotides to the 3’ end
- Elongates lagging strand until it reaches primer of preceding fragment
- 3’→ 5’ exonuclease activty ‘PROOFREADS’ each added nucleotide
DNA polymerase I
- Prokaryotic only
- Degrades RNA primer and replaces it with DNA
- Has the same functions as DNA polymerase III but it also excises RNA primer with 5’→3’ exonuclease
N-formylmethionine stimulates
Neutrophil chemotaxis
RNA polymerase I
Makes rRNA (most numerous RNA, “r”ampant)
RNA polymerase II
Make mRNA (largest RNA, “m”assive)
RNA polymerase III
Makes 5S rRNA, tRNA (smallest RNA, “t”iny)
Eukaryotic RNA polymerases
- No proofreading function but can initiate chains
- RNA polymerase II opens DNA at promoter site
Prokaryotic RNA polymerase
1 RNA polymerase (multisubunit complex) makes all 3 kinds of RNA
α-amanitin
- Found in Amanita phalloides (death cap mushrooms)
- Inhibit RNA polymerase II
- Causes severe hepatotoxicity if ingested
Rifampin
Inhibits RNA polymerase in prokaryotes
Actinomycin D
Inhibits RNA polymerase in both prokaryotes and eukaryotes
Where does mRNA quality control occur
Cytoplasmic processing bodies (P bodies), which contain exonucleases, decapping enzymes, and miRNAs. mRNAs may be stored in P bodies for future translation.
Where are miRNA genes located
In introns
CDKs
Constitutive and inactive
Cyclins
- Regulatory proteins that control cell cycle events
- Phase specific
- Activate CDKs
Cyclin-CDK complexes
- Phosphorylate other proteins to coordinate cell cycle progression
- Must be inactivated and inactivated at appropriate times for cell cycle to progress
Tumor suppressors
- p53 induces p21, which inhibits CDKs → hypophosphorylation (activation) of Rb
- Hypophosphorylation of Rb binds to and inactivates transcrption factor E2F → inhibition of G1-S progression
- Mutations in these genes result in unrestrained cell division (eg Li-Fraumeni)
Permanent cells
- Neurons, skeletal and cardiac muscle, RBCs
- Remain in G0 and regenerate from stem cells
Stable (quiescent) cells
- Hepatocytes, lymphocytes
- Enter G1 from G0 when stimulated
Labile cells
- Bone marrow, gut epithelium, skin, hair follicles, germ cells
- Never go to G0, divide rapidly with a short G1
- Most affected by chemotherapy
Nissl bodies
- Rough endoplasmic reticulum in NEURONS
- Synthesize peptide neurotransmitters for secretion
Golgi protein modifications
- Modifies N-oligosaccharides on aspargine (initially added onto protein in the RER)
- Adds O-oligosaccharides on serine and threonine
- Adds mannose-6-phosphate to proteins for trafficking to lysosomes
Enzyme defect in I-cell disease
N-acetylglucosaminyl-1-phosphotransferase
Signal recognition particle (SRP)
- Abundant, cytosolic ribonucleoprotein that traffics proteins from the ribosome to the RER
- Absent or dysfunctional SRP → proteins accumulate in the cytosol
COPI
- Golgi → golgi (retrograde)
- cis-Golgi → ER
COPII
ER → cis-Golgi (anterograde)
Clathrin
- trans-Golgi → lysosomes
- Plasma membrane → endosomes (receptor mediated endocytosis, eg LDL receptor activity)
Microfilaments
- Muscle contraction, cytokinesis
- Actin, microvilli